Polypeptide production in animal cell culture

Abstract

A method of producing a polypeptide in fed batch cell culture is provided which involves an initial cell growth phase and a distinct production phase. In the initial growth stage, animal cells having nucleic acid encoding the polypeptide are cultured at a starting osmolality of about 280-330 mOsm in the presence of a concentration of glucose controlled throughout the culturing to be within a range between about 0.01 and 1 g/L. This is followed by a production phase, where the cultured animal cells of the growth phase are inoculated at a cell seed density of at least 1.0×10 6 cells/mL and the cells are cultured at a starting osmolarity of about 400-600 mOsm in the presence of a concentration of glucose controlled throughout the culturing to be within a range between about 0.01 and 1 g/L. Preferably, the glutamine concentration in the cell culture medium is simultaneously controlled in order to curtail production of lactic acid and ammonia which result from unnecessarily high glutamine concentrations. During the growth phase, production of potentially detrimental metabolic waste products, such as lactic acid, is controlled thereby curtailing the increase of osmolality due to accumulation and neutralization of waste products. Thus, the cell growth can be improved. In the production phase, the cell culture conditions are modified in order to arrest or reduce cell growth and thereby direct nutrient utilization toward production, as opposed to cell growth. Overall, it is intended that the method results in an improvement in specific productivity, reduction in production run times and/or an increase in final product concentration.

1 . A method of producing an antibody comprising: 
 culturing an animal cell comprising a nucleic acid encoding the antibody in fed batch culture at a starting osmolality of about 280-330 mOsm in the presence of glucose controlled throughout the culturing to be at a concentration between about 0.01 and 1.0 g/L, inclusive, by adding glucose to the cell culture as required to maintain said glucose concentration; and    recovering the antibody from the cell culture medium.    
     
     
         2 . A method of producing an antibody by an animal cell comprising nucleic acid encoding the antibody in fed batch cell culture, comprising culturing the cell at a starting osmolality of about 400-600 mOsm and controlling the glucose concentration in the cell culture to be at a glucose concentration between about 0.01 and 1 g/L, inclusive, throughout the culturing by adding glucose to the cell culture as required to maintain said glucose concentration and thereby controlling the osmolality of the cell culture.  
     
     
         3 - 19 . (canceled)  
     
     
         20 . The method of  claim 1  or  claim 2 , wherein the animal cell is cultured in the presence of glutamine, which glutamine concentration is controlled by adding glutamine to the cell culture as required to maintain said glutamine concentration.  
     
     
         21 . The method of  claim 1  or  claim 2  wherein the glutamine concentration is between about 0.2 and about 2 mM.  
     
     
         22 . The method of  claim 21  wherein the glutamine concentration is between about 0.5 and about 1 mM.  
     
     
         23 . The method of  claim 21  wherein the glucose concentration is between about 0.2 and about 0.5 g/L.  
     
     
         24 . The method of  claim 21  wherein the glucose concentration is between about 0.02 and about 0.2 g/L.  
     
     
         25 . The method of  claim 1  or  claim 2  wherein the culture medium contains excess amino acids.  
     
     
         26 . The method of  claim 1  or  claim 2  wherein the initial cell seed density is between about 3×10 5  and about 1.5×10 6  cells/mL.  
     
     
         27 . The method of  claim 1  or  claim 2  wherein the animal cell is a mammalian cell.  
     
     
         28 . The method of  claim 27  wherein the mammalian cell is a Chinese Hamster Ovary (CHO) cell.  
     
     
         29 . The method of  claim 1  or clam 2 wherein the glucose control comprises flow injection analysis (FIA).